Use Able AI chat for product recommendations

TSC22D2 Polyclonal antibody

TSC22D2 Polyclonal Antibody for WB, IHC, IF/ICC, IP, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human and More (1)

Applications

WB, IHC, IF/ICC, IP, ELISA

KIAA0669, TILZ4, TILZ4a, TILZ4b, TILZ4c

Formulation:  PBS, Azide, Glycerol
PBS, Azide, Glycerol
Conjugate:  Unconjugated
Unconjugated
Size/Concentration: 
SKU: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:

Able AI
Able AI
What's the best dilution for TSC22D2 in ?

Tested Applications

Positive WB detected inHEK-293 cells, MDA-MB-453s cells, HepG2 cells, SH-SY5Y cells
Positive IP detected inHepG2 cells
Positive IHC detected inhuman kidney tissue, human colon tissue, human placenta tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Positive IF/ICC detected inHepG2 cells

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:2000-1:16000
Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunohistochemistry (IHC)IHC : 1:20-1:200
Immunofluorescence (IF)/ICCIF/ICC : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

25418-1-AP targets TSC22D2 in WB, IHC, IF/ICC, IP, ELISA applications and shows reactivity with human samples.

Tested Reactivity human
Cited Reactivityhuman, mouse
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen

CatNo: Ag22294

Product name: Recombinant human TSC22D2 protein

Source: e coli.-derived, PGEX-4T

Tag: GST

Domain: 190-543 aa of BC044643

Sequence: SDSSVLTRSGDCIRHSSTFDQTAERDSGLGATGGSVVVVVASMQGAHGPESGTDSSLTAVSQLPPSEKMSQPTPAQPQSFSVGQPQPPPPPVGGAVAQSSAPLPPFPGAATGPQPMMAAAQPSQPQGAGPGGQTLPPTNVTLAQPAMSLPPQPGPAVGAPAAQQPQQFAYPQPQIPPGHLLPVQPSGQSEYLQQHVAGLQPPSPAQPSSTGAAASPATAATLPVGTGQNASSVGAQLMGASSQPSEAMAPRTGPAQGGQVAPCQPTGVPPATVGGVVQPCLGPAGAGQPQSVPPPQMGGSGPLSAVPGGPHAVVPGVPNVPAAVPAPSVPSVSTTSVTMPNVPAPLAQSQQLSS

Predict reactive species
Full Name TSC22 domain family, member 2
Calculated Molecular Weight 780 aa, 79 kDa
Observed Molecular Weight 100-110 kDa
GenBank Accession NumberBC044643
Gene Symbol TSC22D2
Gene ID (NCBI) 9819
RRIDAB_2880069
Conjugate Unconjugated
FormLiquid
Purification MethodAntigen affinity purification
UNIPROT IDO75157
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

TSC22D2 (transforming growth factor β-stimulated clone 22 domain family, member 2) is a member of the TSC-22 domain family comprising putative transcription factors that are characterized by a carboxy-terminal leucine zipper and an adjacent TSC-box. TSC22D2 is expressed at low levels in CRC and that TSC22D2 overexpression significantly inhibited the growth rate of cancer cells (PMID: 27573352).

Protocols

Product Specific Protocols
IF protocol for TSC22D2 antibody 25418-1-APDownload protocol
IHC protocol for TSC22D2 antibody 25418-1-APDownload protocol
IP protocol for TSC22D2 antibody 25418-1-APDownload protocol
WB protocol for TSC22D2 antibody 25418-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

What published studies show

The TSC22D2 Polyclonal antibody (Cat# 25418-1-AP) has 2 citations. These appear in Clinical and Experimental Medicine and BMC Cancer. The research fields covered include cuproptosis (copper-induced cell death), hepatocyte protection during ischemia-reperfusion injury, and prognostic gene modeling in pancreatic adenocarcinoma. Applications cited include Western blotting and immunohistochemistry in both mouse and human samples.

SpeciesApplicationTitle
mouseWB

Clin Exp Med

HSP90AA1 inhibits the Jun/Fos pathway to rescue hepatocytes from cuproptosis during ischemia-reperfusion injury.

Authors - Songling Xu
humanWB,IHC

BMC Cancer

A novel cuproptosis-related gene model predicts outcomes and treatment responses in pancreatic adenocarcinoma

Authors - Qixian Liu
Loading...
||
New chat

Able®

正在加载,请稍候...